AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 221-240 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
221
Payload Aerospace, S.A.
lowweak
Opp 2
Risk 3

Thesis: Only weak opportunity support is visible in these reviewed sources: membership rationale says the company completed a €180M Series C fundraising, but no representative article, no direct positive evidence, and no in-recent evidence window article detail are provided here, so there is not enough cited support to form a strong 1 year+ opportunity thesis.

Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed.

Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence.

222
Pilot Photonics
lowweak
Opp 2
Risk 1

Thesis: Membership rationale says Pilot Photonics secured a €1 million ESA contract for space photonics development and that the technology addresses satellite communication demands, which could support a modest long-horizon opportunity thesis if contract execution expands.

Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window.

Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction.

223
Pixxel
lowweak
Opp 2
Risk 1

Thesis: Pixxel has a plausible long-horizon opportunity narrative from an external article summary describing a Pixxel-led consortium winning an Indian EO constellation PPP, but that article is dated October 13, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current ranking thesis.

Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025

Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available.

224
Reliance Industries Limited
lowweak
Opp 2
Risk 2

Thesis: There is a possible long-horizon opportunity if Reliance, via Jio Platforms, advances its described LEO satellite communications ambitions, but the reviewed sources does not retain representative article details, or within the recent evidence window evidence to ground that as a current high-conviction thesis.

Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0.

Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view.

225
Remondo
lowweak
Opp 2
Risk 2

Thesis: Older context suggests a potentially differentiated Earth-observation approach, with a first mission planned in 2027 to demonstrate a partial aperture imaging system, but this falls outside the active evidence recent evidence window and is insufficient for a strong current rank.

Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis.

Evidence
  • February 23, 2026: Remondo plans to launch its first mission in 2027 to demonstrate what it calls a partial aperture imaging system, or PAIS. spacenews.com
  • The article frames the key milestone as a planned first mission in 2027, implying development-stage execution risk; however, this evidence is outside the recent evidence window. spacenews.com

Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited.

226
Rhea Space Activity
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says Rhea Space Activity raised about $6 million in Series A financing for GPS-denied navigation software targeting military and intelligence customers, which would be a constructive long-horizon signal if confirmed by available evidence, but this screen contains no usable within the recent evidence window evidence or article.

Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested.

Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence.

227
Rocket One, Inc.
lowweak
Opp 2
Risk 2

Thesis: Among this screen, Rocket One has the strongest contextual indication of a strategic pivot toward space/defense AI chips and nano-launch or nanosatellite enablement, which could become a long-horizon opportunity if later corroborated by direct execution evidence. However, these reviewed sources have no direct positive evidence inside the recent evidence window, so the thesis remains weak.

Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering.

228
Rogue Space Systems
lowweak
Opp 2
Risk 1

Thesis: There is limited relevance support that Rogue Space Systems is an operating in-orbit servicing company, which is directionally compatible with a long-horizon commercial space opportunity view, but the evidence is only undated directory-style context and not direct positive operating proof.

Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain.

Evidence
  • Space Index lists Rogue Space Systems, HQ Laconia, New Hampshire, USA, status 'operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context. spaceindex.io

Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included.

229
RTX Corporation
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources' membership rationale references involvement in U.S. Space Force and missile-warning programs, which could support long-horizon opportunity, but no within the recent evidence window direct evidence or representative article summaries are available for scoring in this screen.

Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence.

Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence.

230
Sanyark Space Technologies
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources places Sanyark Space Technologies in a spacetech accelerator among startups working on rocket propulsion, satellites, and space energy. That supports a possible early-stage opportunity setup, but the reviewed sources does not specify which activities belong to Sanyark itself and provides no direct evidence row or (: not provided in reviewed sources).

Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure.

Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available.

231
Satellogic Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources membership rationale describes Satellogic as an Earth observation/geospatial company with constellation and monitoring contracts, which could be constructive over a 1 year+ horizon, but no available current evidence supports a stronger call.

Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence.

232
SatixFy
lowweak
Opp 2
Risk 2

Thesis: Phase-2 rationale references SatixFy as an Israeli chipmaker acquired by MDA Space with first space-grade chips shipped, which may indicate strategic relevance, but there are no retained in-window evidence here.

Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone.

Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence.

233
SatSure Analytics India Pvt. Ltd.
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence context indicates SatSure is developing a large Earth Observation AI model and received IN-SPACe Technology Adoption Fund support including a ₹24.6 crore grant, which could support longer-horizon capability building, but no direct post-recent evidence window evidence are available to validate timing, scale, or current business momentum in the next 1 year+ horizon.

Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only.

234
SatVu
lowweak
Opp 2
Risk 1

Thesis: An external article says SatVu closed a £30m funding round, which is positive financing context, but that article is dated February 17, 2026 and was dropped by the 90-day recent evidence policy, so it cannot support a strong current opportunity ranking

Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy.

Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score.

235
Scale AI
lowweak
Opp 2
Risk 1

Thesis: Membership rationale says Scale AI received a U.S. Space Force Golden Dome contract as part of an approximately $3.2 billion award group, which, if current and durable, could support a meaningful public-sector space/defense opportunity over a 1 year+ horizon.

Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope.

Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion.

236
Schaeffler AG
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Schaeffler planned a collaboration with Spire on satellite bus manufacturing and RF sensing, which suggests strategic adjacency to space systems, but there is no available within the recent evidence window direct evidence to underwrite a durable opportunity thesis.

Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence.

Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources.

237
SEALCOIN AG
lowweak
Opp 2
Risk 1

Thesis: There is a hint of financing-related progress in space-based blockchain infrastructure, but the reviewed sources lack retained direct evidence strong enough to support a robust opportunity thesis.

Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window.

Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself.

238
Sidus Space Inc.
lowweak
Opp 2
Risk 3

Thesis: The membership rationale indicates Sidus Space operates LizzieSat satellites, manufacturing, and customer contracts, which could support a long-horizon operating-space-company thesis, but this screen includes no available within the recent evidence window article summaries or evidence to evaluate direction.

Why now: Why now is weak because although the company had 44 considered articles, the reviewed sources show articles after recent evidence window = 0 and evidence after recent evidence window = 0, so the current business state is not evidenced here.

Caveats: Phase-2 membership rationale references: and: but no or available evidence are provided. A large historical article universe should not be mistaken for conviction. No within the recent evidence window direct evidence is available for ranking.

239
Sift
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources hints at potential opportunity from Sift raising $42 million and building AI infrastructure for mission-critical hardware including space and defense, but no kept citable evidence or are provided here.

Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon.

Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence.

240
Silicon Microgravity
lowweak
Opp 2
Risk 2

Thesis: There is modest theoretical opportunity because the reviewed sources' membership rationale says Silicon Microgravity received £500K in UK space funding, but no reviewed evidence row or citable article is supplied here.

Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary.

Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence.

Risk view

Showing rows 381-400 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
381
Spaceworks
lowweak
Opp 1
Risk 1

Thesis: No retained adverse evidence is provided, so no evidence-based risk thesis can be made.

Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included.

Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction.

382
SSC Space
lowweak
Opp 1
Risk 1

Thesis: No material negative thesis is supportable from these reviewed sources because no direct negative evidence remains after recent evidence filtering.

Why now: There is no retained within the recent evidence window evidence for a current catalyst.

Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided.

383
ST Engineering
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources. Risk is limited to evidentiary uncertainty and boundary ambiguity around whether this specific activity is meaningful to ST Engineering's forward space thesis, not to a negative company event (: not provided in reviewed sources).

Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported.

Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence.

384
Star Catcher Industries, Inc.
lowweak
Opp 1
Risk 1

Thesis: There is also no direct adverse evidence retained inside the 90-day recent evidence window, so no material risk thesis is supported beyond normal uncertainty from missing current evidence.

Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources.

Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis.

385
Starfighters Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space.

Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation.

386
Starfish Space
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources have no retained 90-day adverse evidence, so there is not enough for a risk thesis.

Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources.

Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction.

387
Starlab
lowweak
Opp 1
Risk 1

Thesis: No material risk thesis is supportable because the reviewed sources retains no direct negative evidence within the recent evidence window.

Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab.

Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here.

388
StatSat
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not retain sufficient company-specific adverse evidence to support a risk thesis.

Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain.

Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources.

389
Swedish Space Corporation
lowweak
Opp 1
Risk 1

Thesis: No material adverse company-specific evidence is available in the retained recent evidence window. Risk score is kept slightly above zero only because coverage is thin and business status is unconfirmed in the reviewed sources.

Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources.

Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof.

390
SWISSto12
lowweak
Opp 0
Risk 1

Thesis: No material adverse evidence is shown. The low risk score reflects lack of documented negatives rather than evidence of resilience.

Why now: There is no identifiable catalyst because the reviewed sources provide only a passing mention and no direct event or fact evidence.

Caveats: No current evidence is provided for. Support level is provisional single-article context only. No evidence available after recent evidence window.

391
Swoop Technologies
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is present. The main risk is that the company may be only tangentially relevant to the targeted space themes, making the opportunity thesis weak rather than making the company negatively exposed (: not provided in reviewed sources).

Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context.

Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available.

392
TelePIX
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available in the reviewed sources, but absence of current retained evidence means business execution, financing, and mission timing remain uncertain.

Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article

Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0.

393
Telesat Corp
lowweak
Opp 1
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is available in the reviewed sources, so there is not enough support for a material risk thesis.

Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call.

Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence.

394
TESAT
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is present. The main limitation is evidentiary: TESAT's relevance may be real, but the reviewed sources does not provide company-specific directional evidence for either upside or downside (: not provided in reviewed sources).

Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument.

Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available.

395
TESAT Spacecom
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is provided; risk remains low because the reviewed sources contain only context-level mention.

Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context.

Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence.

396
Thales
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supported by the reviewed sources. The more relevant issue is uncertainty over evidence attribution from Thales Alenia Space to Thales parent.

Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window.

397
The ePlane Company
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is available. The main downside is uncertainty about business fit, commercialization path, and whether the government-support reference is meaningful at the company level.

Why now: The government RDI disbursal reference could matter on a 1 year+ horizon, but the reviewed sources lack timestamps, and direct evidence, limiting confidence in timing and materiality.

Caveats: No current evidence is provided for Government support mention is contextual and not enough alone to prove commercial traction. Zero evidence available after recent evidence window.

398
Trishul Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available within the recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence.

399
True Anomaly
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is available. Risk remains low-scored due to lack of evidence rather than demonstrated business stability.

Why now: Why-now is weak because the cited raise and mission activity appear only in membership rationale, without scoreable dated article details in the current evidence set.

Caveats: Membership rationale cites, and, but the supporting articles are not available for direct use. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. A positive thesis requires positive evidence; membership rationale alone only supports a modest watchlist bias.

400
True Anomaly Centennial
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources. Risk remains low-scored only because evidence is absent, not because the business is proven safe.

Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch.

Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence.